Whole slide image based deep learning refines prognosis and therapeutic response evaluation in lung adenocarcinoma
Authors:
Open Access
- 29 January 2025
- journal article
- research article
- Published by Springer Nature in npj Digital Medicine
- Vol. 8 (1) , 1-12
Abstract
Existing prognostic models are useful for estimating the prognosis of lung adenocarcinoma patients, but there remains room for improvement. In the current study, we developed a deep learning model based on histopathological images to predict the recurrence risk of lung adenocarcinoma patients. The efficiency of the model was then evaluated in independent multicenter cohorts. The model defined high- and low-risk groups successfully stratified prognosis of the entire cohort. Moreover, multivariable Cox analysis identified the model defined risk groups as an independent predictor for disease-free survival. Importantly, combining TNM stage with the established model helped to distinguish subgroups of patients with high-risk stage II and stage III disease who are highly likely to benefit from adjuvant chemotherapy. Overall, our study highlights the significant value of the constructed model to serve as a complementary biomarker for survival stratification and adjuvant therapy selection for lung adenocarcinoma patients after resection.Keywords
Funding Information
- National Key Research and Development Program of China
This publication has 28 references indexed in Scilit:
- End-to-end prognostication in colorectal cancer by deep learning: a retrospective, multicentre studyThe Lancet Digital Health, 2023
- Machine learning-based immune phenotypes correlate with STK11/KEAP1 co-mutations and prognosis in resectable NSCLC: a sub-study of the TNM-I trialAnnals of Oncology, 2023
- Clinicopathologic and Genotypic Features of Lung Adenocarcinoma Characterized by the International Association for the Study of Lung Cancer Grading SystemJournal of Thoracic Oncology, 2022
- A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology CommitteeJournal of Thoracic Oncology, 2020
- Predicting Survival After Hepatocellular Carcinoma Resection Using Deep Learning on Histological SlidesHepatology, 2020
- Prognostic factors including lymphovascular invasion on survival for resected non–small cell lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 2018
- The Eighth Edition Lung Cancer Stage ClassificationChest, 2017
- Visceral Pleural Invasion Remains a Size-Independent Prognostic Factor in Stage I Non-Small Cell Lung CancerThe Annals of Thoracic Surgery, 2015
- Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trialThe Lancet Oncology, 2006
- Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial1European Journal of Cardio-Thoracic Surgery, 2004